vs

Side-by-side financial comparison of Vericel Corp (VCEL) and Via Renewables, Inc. (VIASP). Click either name above to swap in a different company.

Via Renewables, Inc. is the larger business by last-quarter revenue ($127.8M vs $92.9M, roughly 1.4× Vericel Corp). Vericel Corp runs the higher net margin — 25.0% vs 5.4%, a 19.7% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 22.5%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $-4.8M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 5.9%).

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.

EDF Power Solutions is a wholly owned subsidiary of the French utility EDF Group, specializing in renewable energy production. As an integrated operator, the Group develops and finances the construction of renewable energy facilities, and manages operations and maintenance for its own account and for third parties.

VCEL vs VIASP — Head-to-Head

Bigger by revenue
VIASP
VIASP
1.4× larger
VIASP
$127.8M
$92.9M
VCEL
Growing faster (revenue YoY)
VCEL
VCEL
+0.8% gap
VCEL
23.3%
22.5%
VIASP
Higher net margin
VCEL
VCEL
19.7% more per $
VCEL
25.0%
5.4%
VIASP
More free cash flow
VCEL
VCEL
$17.6M more FCF
VCEL
$12.8M
$-4.8M
VIASP
Faster 2-yr revenue CAGR
VCEL
VCEL
Annualised
VCEL
34.6%
5.9%
VIASP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
VCEL
VCEL
VIASP
VIASP
Revenue
$92.9M
$127.8M
Net Profit
$23.2M
$6.9M
Gross Margin
78.7%
34.4%
Operating Margin
24.1%
15.2%
Net Margin
25.0%
5.4%
Revenue YoY
23.3%
22.5%
Net Profit YoY
17.3%
-30.9%
EPS (diluted)
$0.46
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
VCEL
VCEL
VIASP
VIASP
Q4 25
$92.9M
$127.8M
Q3 25
$67.5M
$103.3M
Q2 25
$63.2M
$90.0M
Q1 25
$52.6M
$142.3M
Q4 24
$75.4M
$104.3M
Q3 24
$57.9M
$93.8M
Q2 24
$52.7M
$86.7M
Q1 24
$51.3M
$114.1M
Net Profit
VCEL
VCEL
VIASP
VIASP
Q4 25
$23.2M
$6.9M
Q3 25
$5.1M
$757.0K
Q2 25
$-553.0K
$2.7M
Q1 25
$-11.2M
$8.8M
Q4 24
$19.8M
$9.9M
Q3 24
$-901.0K
$2.1M
Q2 24
$-4.7M
$7.6M
Q1 24
$-3.9M
$8.6M
Gross Margin
VCEL
VCEL
VIASP
VIASP
Q4 25
78.7%
34.4%
Q3 25
73.5%
23.1%
Q2 25
73.7%
30.0%
Q1 25
69.0%
32.9%
Q4 24
77.6%
51.9%
Q3 24
71.9%
26.8%
Q2 24
69.5%
50.4%
Q1 24
68.9%
39.5%
Operating Margin
VCEL
VCEL
VIASP
VIASP
Q4 25
24.1%
15.2%
Q3 25
5.1%
3.1%
Q2 25
-3.2%
6.7%
Q1 25
-24.3%
17.5%
Q4 24
24.5%
31.5%
Q3 24
-4.3%
5.3%
Q2 24
-11.5%
23.8%
Q1 24
-10.7%
22.6%
Net Margin
VCEL
VCEL
VIASP
VIASP
Q4 25
25.0%
5.4%
Q3 25
7.5%
0.7%
Q2 25
-0.9%
3.0%
Q1 25
-21.4%
6.2%
Q4 24
26.3%
9.5%
Q3 24
-1.6%
2.3%
Q2 24
-8.9%
8.8%
Q1 24
-7.5%
7.5%
EPS (diluted)
VCEL
VCEL
VIASP
VIASP
Q4 25
$0.46
$1.19
Q3 25
$0.10
$-0.41
Q2 25
$-0.01
$0.09
Q1 25
$-0.23
$1.83
Q4 24
$0.40
$2.33
Q3 24
$-0.02
$-0.17
Q2 24
$-0.10
$1.51
Q1 24
$-0.08
$1.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
VCEL
VCEL
VIASP
VIASP
Cash + ST InvestmentsLiquidity on hand
$137.5M
$41.8M
Total DebtLower is stronger
$120.0M
Stockholders' EquityBook value
$354.6M
$67.7M
Total Assets
$488.0M
$331.3M
Debt / EquityLower = less leverage
1.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
VCEL
VCEL
VIASP
VIASP
Q4 25
$137.5M
$41.8M
Q3 25
$135.4M
$53.6M
Q2 25
$116.9M
$62.1M
Q1 25
$112.9M
$64.7M
Q4 24
$116.2M
$53.1M
Q3 24
$101.7M
$66.6M
Q2 24
$102.5M
$53.6M
Q1 24
$110.6M
$50.4M
Total Debt
VCEL
VCEL
VIASP
VIASP
Q4 25
$120.0M
Q3 25
$105.0M
Q2 25
$100.0M
Q1 25
$101.0M
Q4 24
$106.0M
Q3 24
$89.0M
Q2 24
$93.0M
Q1 24
$91.0M
Stockholders' Equity
VCEL
VCEL
VIASP
VIASP
Q4 25
$354.6M
$67.7M
Q3 25
$321.9M
$63.7M
Q2 25
$306.8M
$68.2M
Q1 25
$295.5M
$72.7M
Q4 24
$292.0M
$66.7M
Q3 24
$257.5M
$58.2M
Q2 24
$243.0M
$58.3M
Q1 24
$233.9M
$53.2M
Total Assets
VCEL
VCEL
VIASP
VIASP
Q4 25
$488.0M
$331.3M
Q3 25
$453.3M
$304.8M
Q2 25
$435.6M
$316.3M
Q1 25
$424.6M
$347.4M
Q4 24
$432.7M
$344.9M
Q3 24
$390.4M
$298.4M
Q2 24
$376.8M
$299.7M
Q1 24
$356.7M
$302.7M
Debt / Equity
VCEL
VCEL
VIASP
VIASP
Q4 25
1.77×
Q3 25
1.65×
Q2 25
1.47×
Q1 25
1.39×
Q4 24
1.59×
Q3 24
1.53×
Q2 24
1.60×
Q1 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
VCEL
VCEL
VIASP
VIASP
Operating Cash FlowLast quarter
$15.0M
$-4.2M
Free Cash FlowOCF − Capex
$12.8M
$-4.8M
FCF MarginFCF / Revenue
13.8%
-3.7%
Capex IntensityCapex / Revenue
2.4%
0.4%
Cash ConversionOCF / Net Profit
0.65×
-0.61×
TTM Free Cash FlowTrailing 4 quarters
$24.7M
$39.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
VCEL
VCEL
VIASP
VIASP
Q4 25
$15.0M
$-4.2M
Q3 25
$22.1M
$2.4M
Q2 25
$8.2M
$19.0M
Q1 25
$6.6M
$24.9M
Q4 24
$22.2M
$2.0M
Q3 24
$10.2M
$20.1M
Q2 24
$18.5M
$11.2M
Q1 24
$7.2M
$17.1M
Free Cash Flow
VCEL
VCEL
VIASP
VIASP
Q4 25
$12.8M
$-4.8M
Q3 25
$19.5M
$1.9M
Q2 25
$81.0K
$18.4M
Q1 25
$-7.6M
$23.5M
Q4 24
$8.5M
$1.6M
Q3 24
$-9.2M
$19.7M
Q2 24
$1.8M
$10.9M
Q1 24
$-6.8M
$16.6M
FCF Margin
VCEL
VCEL
VIASP
VIASP
Q4 25
13.8%
-3.7%
Q3 25
28.8%
1.9%
Q2 25
0.1%
20.5%
Q1 25
-14.5%
16.5%
Q4 24
11.2%
1.5%
Q3 24
-15.9%
21.0%
Q2 24
3.4%
12.6%
Q1 24
-13.3%
14.6%
Capex Intensity
VCEL
VCEL
VIASP
VIASP
Q4 25
2.4%
0.4%
Q3 25
3.9%
0.4%
Q2 25
12.9%
0.6%
Q1 25
27.0%
1.0%
Q4 24
18.3%
0.4%
Q3 24
33.5%
0.4%
Q2 24
31.8%
0.3%
Q1 24
27.3%
0.4%
Cash Conversion
VCEL
VCEL
VIASP
VIASP
Q4 25
0.65×
-0.61×
Q3 25
4.35×
3.12×
Q2 25
6.94×
Q1 25
2.84×
Q4 24
1.12×
0.20×
Q3 24
9.41×
Q2 24
1.47×
Q1 24
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

VCEL
VCEL

MACI Implants And Kits$84.1M90%
Other$8.8M10%

VIASP
VIASP

Retail Electricity$79.7M62%
Retail Natural Gas$48.9M38%

Related Comparisons